Regeneron Pharmaceuticals
REGN
#254
Rank
A$120.01 B
Marketcap
$1,098
Share price
-1.99%
Change (1 day)
-26.14%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2024 (TTM): A$7.20 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$14.20 Billion. , an increase over its 2023 earnings that were of A$6.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2024

Annual earnings

Year Earnings Change
2024 A$7.66 B13.83%
2023 A$6.73 B-13.57%
2022 A$7.78 B-47.9%
2021 A$14.94 B144.75%
2020 A$6.10 B56.86%
2019 A$3.89 B-4.87%
2018 A$4.09 B22.86%
2017 A$3.33 B56.3%
2016 A$2.13 B8.55%
2015 A$1.96 B54.53%
2014 A$1.27 B11.14%
2013 A$1.14 B72.13%
2012 A$0.66 B-285.93%
2011 -A$0.36 Billion121.73%
2010 -A$0.17 Billion37.18%
2009 -A$0.12 Billion-14.6%
2008 -A$0.14 Billion-25.02%
2007 -A$0.19 Billion6.32%
2006 -A$0.18 Billion-186.52%
2005 A$0.19 B2103.7%
2004 A$9.04 M-105.66%
2003 -A$0.16 Billion-18.18%
2002 -A$0.2 Billion42.33%
2001 -A$0.14 Billion129.35%
2000 -A$59.89 Million51.87%
1999 -A$39.44 Million92.19%
1998 -A$20.52 Million66.23%
1997 -A$12.35 Million-55.49%
1996 -A$27.73 Million103.53%
1995 -A$13.63 Million-70.89%
1994 -A$46.81 Million-26.08%
1993 -A$63.32 Million114.67%
1992 -A$29.5 Million196.77%
1991 -A$9.94 Million87.88%
1990 -A$5.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.38 B-3.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.38 Billion-104.93%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.05 B-60.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$27.95 B 264.90%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.86 B 185.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$12.72 B 66.15%๐Ÿ‡ซ๐Ÿ‡ท France